Dr. Thomas Charles Sroka, MD

  • Eugene, OR
  • Radiation oncologist
NPI1700058021PAC ID6709035413
Medicare services, 2024
2,395
Medicare patients, 2024
214
Part D claims, 2024
170
Publications
10
Hospital affiliations
2
Practice address
520 Country Club Pkwy, Eugene, OR 97401
Practice phone
Call (541) 683-5001
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Willamette Valley Cancer Institute and Research Center

Eugene, Oregon

See all 5 affiliations

Find Dr. Sroka's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Thomas Charles Sroka is a radiation oncologist in Eugene, Oregon

Dr. Sroka practices at Willamette Valley Cancer Institute and Research Center in Eugene, Oregon.

Dr. Sroka's NPI, 1700058021, was assigned on March 26, 2008. Dr. Sroka graduated from University of Arizona College of Medicine in 1997. Dr. Sroka holds Oregon license MD172744.

NPI and contact details
Medicare PAC ID
6709035413
NPI enumeration date
March 26, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(541) 683-5001
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
55
Medical school graduation
1997

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Thomas Charles Sroka practices at Willamette Valley Cancer Institute and Research Center in Eugene, Oregon

Dr. Sroka's primary practice is Willamette Valley Cancer Institute and Research Center, at 520 Country Club Pkwy, Eugene, OR 97401 in Lane County. The practice phone is (541) 683-5001.

  • Willamette Valley Cancer Institute and Research Center
    520 Country Club Pkwy, Eugene, OR 97401 · Lane CountyPhone(541) 683-5001

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Thomas Charles Sroka is affiliated with 4 sites of care and 1 medical group

Dr. Sroka's primary practice is Willamette Valley Cancer Institute and Research Center in Eugene, Oregon. Dr. Sroka is also affiliated with PeaceHealth Sacred Heart Medical Center RiverBend. The medical group on file is Willamette Valley Cancer Institute & Research Center. Dmand AI also links Dr. Sroka to 1 more hospital and 1 group practice or clinic, each named with a free account.

See all 5 affiliations for Dr. Sroka

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Thomas Charles Sroka's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sroka practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Willamette Valley Cancer Institute and Research CenterAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Sroka practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Thomas Charles Sroka is one of 98 radiation oncologists in Oregon

Radiation oncology is Dr. Sroka's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Sroka's licenses on file in 3 states: Oregon, Arizona and New Hampshire.

Specialties and state licenses

  • Radiation oncology, OregonPrimaryLicense MD172744 · taxonomy 2085R0001X
  • Arizona licenseLicense 82131
  • New Hampshire licenseLicense 15775

Radiation oncologists near Dr. Sroka

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

98radiation oncologists in Oregon
5radiation oncologists in Eugene

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Thomas Charles Sroka billed Medicare for 2,395 services in 2024

CMS data shows 2,395 Medicare services from Dr. Sroka across 25 procedure codes in 2024, for 214 Medicare patients. Medicare paid $411,132 for them. Every service was in an office.

Medicare services, 20242,395
Medicare patients214
Paid by Medicare$411,132
Procedure codes25

Dr. Sroka's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 1,4982024: 1,29314%
Other services
2023: 8562024: 8681%
Office and hospital visits
2023: 1692024: 1681%
Surgery
2023: 452024: 3718%
Lab and pathology
2023: 392024: 2926%

Dr. Sroka compared with the Oregon median for radiation oncologists, 2024

  • Dr. Sroka
  • Oregon median
Medicare services
2,395vs 8392.9 times
Medicare patients
214vs 14053% above
Part D claims
97vs 472.1 times

Medians across 99 radiation oncologists in Oregon with Dmand AI profiles that report each measure.

Dr. Sroka's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Sroka

Need commercial claims for Dr. Sroka?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sroka and other radiation oncologists in Oregon.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Thomas Charles Sroka treated 214 Medicare patients in 2024, average age 74

CMS counts 214 Medicare patients who saw Dr. Sroka in 2024. The largest group is 65 to 74, with 103 patients. 74% of them have cancer, and 66% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sroka's median patient age at 72, with 45% women.

Medicare patients, 2024214
Average age74
Average risk score1.71
Also on Medicaid18%

Dr. Sroka's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Sroka's Medicare patients by sex, 2024

  • Women10147%
  • Men11353%

Chronic conditions among Dr. Sroka's Medicare patients, 2024

  1. Cancer74%
  2. High blood pressure66%
  3. High cholesterol62%
  4. Arthritis35%
  5. Chronic kidney disease26%
  6. Anxiety25%
  7. COPD24%
  8. Ischemic heart disease22%

Share of Medicare patients with each condition. A patient can have several.

Dr. Sroka's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women45%
  • Men54%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Thomas Charles Sroka wrote 170 Medicare Part D claims in 2024

In 2024, Dr. Sroka wrote 170 Medicare Part D claims for 61 patients. 98% of them were for generic drugs. CMS names the drug for 97 of them, across 3 drugs with 11 or more claims each, at $1,184 in total drug cost. In 2023, CMS named 88 claims across 3 drugs.

Part D claims, 2024170
Drugs named by CMS3
Total drug cost$1,184
Part D patients61

Dr. Sroka's Part D claims by kind of drug, 2024

  • Generic167 claims98%
  • Brand-name and other3 claims2%

Dr. Sroka's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Sroka's Part D claims, 2024

  • Opioids14%24 of 170 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 882024: 9710%

Drugs named by CMS: 3 in 2024, 3 in 2023.

See all prescribing by Dr. Sroka

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Thomas Charles Sroka offers telehealth to Medicare patients

Dr. Sroka accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sroka as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find radiation oncologists like Dr. Sroka by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Thomas Charles Sroka has 10 publications on record

Dmand AI links 10 papers to Dr. Sroka, published from 2011 to 2015. 2013 was the busiest year, with 2. The most frequent topics are Head and Neck Neoplasms, Feasibility Studies and Radiation Injuries. Dr. Sroka has published most often in Front Oncol. Dr. Sroka's most frequent co-authors are Rick D. Davis, MD, Anand Desai and Anand Bharat Desai, MD.

Papers10
Years published2011 to 2015

Dr. Sroka's papers by year, 2011 to 2015

Topics Dr. Sroka writes about most

  • Head and Neck Neoplasms
  • Feasibility Studies
  • Radiation Injuries
  • Radiotherapy Dosage
  • Radiotherapy, Image-Guided
  • Radiotherapy, Intensity-Modulated
  • Radiotherapy Planning, Computer-Assisted
  • Arizona

Dr. Sroka's most frequent co-authors

Recent publications by Dr. Sroka

See all 10 publications and co-authors

See who Dr. Sroka researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sroka works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Thomas Charles Sroka received $732 in industry payments from 2016 to 2025

CMS Open Payments shows 11 general payments to Dr. Sroka from 4 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 71% of the total. Siemens Medical Solutions USA, Inc. paid the most, $617.

General payments to Dr. Sroka by program year, 2016 to 2025

General payments to Dr. Sroka by kind, 2016 to 2025

$732in total
  • Travel and lodging$51671%
  • Food and beverage$21629%

Companies that paid Dr. Sroka the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Sroka

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Thomas Charles Sroka graduated from University of Arizona College of Medicine

Dr. Sroka graduated from University of Arizona College of Medicine in 1997.

  1. Medical schoolUniversity of Arizona College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Thomas Charles Sroka's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Thomas Charles Sroka

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Thomas Charles Sroka's NPI number?

Dr. Thomas Charles Sroka's NPI number is 1700058021. It was assigned on March 26, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Thomas Charles Sroka?

Dr. Thomas Charles Sroka is a radiation oncologist in Eugene, Oregon. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Thomas Charles Sroka practice?

Dr. Sroka practices at 520 Country Club Pkwy, Eugene, OR 97401. Dr. Sroka's primary practice is Willamette Valley Cancer Institute and Research Center in Eugene, Oregon. Dmand AI also links Dr. Sroka to 1 hospital and 1 group practice or clinic.

What is Dr. Thomas Charles Sroka's office phone number?

The practice phone on file for Dr. Sroka is (541) 683-5001.

What is Dr. Thomas Charles Sroka's medical license number?

Dr. Sroka holds Oregon license MD172744, one of the licenses on file in 3 states.

Which states has Dr. Thomas Charles Sroka been licensed in?

Dmand AI has state licenses on file for Dr. Sroka in Oregon, Arizona and New Hampshire.

Which hospitals is Dr. Thomas Charles Sroka affiliated with?

Dr. Sroka is affiliated with PeaceHealth Sacred Heart Medical Center RiverBend. Dmand AI links Dr. Sroka to 1 more hospital.

What medical group is Dr. Thomas Charles Sroka part of?

Dr. Sroka is linked to Willamette Valley Cancer Institute & Research Center.

Does Dr. Thomas Charles Sroka accept Medicare?

Yes. CMS data shows Dr. Sroka billed Medicare for 2,395 services in 2024, and Dr. Sroka accepts Medicare assignment.

Does Dr. Thomas Charles Sroka offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Sroka as offering telehealth services.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Thomas Charles Sroka see?

CMS counts 214 Medicare patients who saw Dr. Sroka in 2024, with an average age of 74.

What services does Dr. Thomas Charles Sroka bill to Medicare?

In 2024, Dr. Sroka's most billed Medicare services were radiation oncology (77014), medicare service (G6015) and radiation oncology (77336).

Where did Dr. Thomas Charles Sroka go to medical school?

Dr. Sroka graduated from University of Arizona College of Medicine in 1997.

What drugs does Dr. Thomas Charles Sroka prescribe most?

In 2024 Medicare Part D data, Dr. Sroka's most prescribed drugs by claims were Tamsulosin HCl, Oxycodone HCl and Levothyroxine Sodium.

Has Dr. Thomas Charles Sroka received payments from drug or device companies?

CMS Open Payments shows $732 in general payments to Dr. Sroka from 4 companies from 2016 to 2025. The largest total came from Siemens Medical Solutions USA, Inc.

How long has Dr. Thomas Charles Sroka been practicing?

Dr. Sroka graduated from medical school in 1997, 29 years ago.

Does Dr. Thomas Charles Sroka do research?

Dmand AI links 10 publications to Dr. Sroka, published from 2011 to 2015.

Who does Dr. Thomas Charles Sroka publish with?

Dr. Sroka's most frequent co-authors are Rick D. Davis, MD (4 shared papers), Anand Desai (4 shared papers) and Anand Bharat Desai, MD (4 shared papers).

Selling to radiation oncology practices?

See radiation oncologists in Oregon by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)